Avenue Therapeutics Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ATXI Avenue Therapeutics Inc.

Market Closed 05-10 16:00:00 EDT

4.00

-0.15

-3.61%

盘后3.96

-0.04-1.00%

19:59 EDT

High4.29	Low4.00	Vol90.59K
Open4.18	D1 Closing4.15	Amplitude6.94%
Mkt Cap3.08M	Tradable Cap2.72M	Total Shares769.80K
T/O373.83K	T/O Rate13.34%	Tradable Shares679.08K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ATXI","market":"US","secType":"STK","nameCN":"Avenue Therapeutics Inc.","latestPrice":4,"timestamp":1715371200000,"preClose":4.15,"halted":0,"volume":90588,"hourTrading":{"tag":"盘后","latestPrice":3.96,"preClose":4,"latestTime":"19:59 EDT","volume":4743,"amount":18572.2772,"timestamp":1715385595822},"delay":0,"floatShares":679076,"shares":769796,"eps":-73.480125,"marketStatus":"Market Closed","change":-0.15,"latestTime":"05-10 16:00:00 EDT","open":4.18,"high":4.2881,"low":4,"amount":373827.053724,"amplitude":0.069422,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-73.480125,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1715587200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1497585600000,"exchange":"NASDAQ","adjPreClose":4.15,"preHourTrading":{"tag":"盘前","latestPrice":4.25,"preClose":4.15,"latestTime":"09:22 EDT","volume":750,"amount":3163.627275,"timestamp":1715347332404},"postHourTrading":{"tag":"盘后","latestPrice":3.96,"preClose":4,"latestTime":"19:59 EDT","volume":4743,"amount":18572.2772,"timestamp":1715385595822},"volumeRatio":0.26364469261983975},"requestUrl":"/m/hq/s/ATXI","defaultTab":"news","newsList":[{"id":"2434917318","title":"BRIEF-Avenue Therapeutics May Offer Shares Of Common Stock Having Offering Price Of Up To $3.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2434917318","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2434917318?lang=en_us&edition=fundamental","pubTime":"2024-05-11 04:55","pubTimestamp":1715374556,"startTime":"0","endTime":"0","summary":"May 10 (Reuters) - Avenue Therapeutics Inc   :   * AVENUE THERAPEUTICS INC: MAY OFFER SHARES OF COMMON STOCK HAVING OFFERING PRICE OF UP TO $3.9 MILLION FROM TIME TO TIME THROUGH AGENTSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431189061","title":"FLGC, BTOG and CAUD among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431189061","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431189061?lang=en_us&edition=fundamental","pubTime":"2024-04-30 00:31","pubTimestamp":1714408290,"startTime":"0","endTime":"0","summary":"Gainers: Collective Audience  +93%. Deciphera Pharmaceuticals  +72%. HWH International  +40%. Mullen Automotive  +32%. SEP Acquisition Corp  +30%. Bit Origin Ltd  +30%. SINTX Technologies  +32%. Koninklijke Philips N.V.  +28%. Phibro Animal Health Corp.  +27%.  Soleno Therapeutics  +25%.  Losers: Clever Leaves Holdings  -61%. Annovis Bio  -56%. Addex Therapeutics Ltd  -48%. mF International Ltd  -32%. Avenue Therapeutics  -23%. Intelligent Group Ltd  -19%. Nature Wood Group Ltd  -19%. Flora Growth Corp  -18%. China Jo-Jo Drugstores  -17%. Fitell Corp  -17%.","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095678-flgc-btog-and-caud-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431786468","title":"ImmunityBio, Aquestive Therapeutics, Clever Leaves Holdings among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431786468","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431786468?lang=en_us&edition=fundamental","pubTime":"2024-04-29 22:02","pubTimestamp":1714399374,"startTime":"0","endTime":"0","summary":"Gainers: Deciphera Pharmaceuticals  +72%. Koninklijke Philips N.V. ADR  +35%. ImmunityBio  +38%. Soleno Therapeutics  +31%. ZyVersa Therapeutics  +23%.  Losers: Clever Leaves Holdings  -59%. Addex Therapeutics Ltd ADR  -50%. China Jo-Jo Drugstores  -20%. Avenue Therapeutics  -22%.  Aquestive Therapeutics  -17%.  S&P 500 Health Care Sector +0.52% to 1639.33. Health Care Equipment & Services +0.39% to 1936.74. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.67% to 1326.27.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095502-immunitybio-aquestive-therapeutics-clever-leaves-holdings-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431859408","title":"ALT, CYCC and DB among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431859408","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431859408?lang=en_us&edition=fundamental","pubTime":"2024-04-29 20:17","pubTimestamp":1714393057,"startTime":"0","endTime":"0","summary":"Losers: Clever Leaves Holdings  -61% announces Voluntary Delisting and SEC Deregistration. Addex Therapeutics Ltd  -52% provides update on ADX71149 phase 2 Epilepsy study. Cyclacel Pharmaceuticals  -21%. Nature Wood Group Ltd  -15%. mF International Ltd  -14%. Biodexa Pharmaceuticals  -11%.  Avenue Therapeutics  -11% announces exercise of warrants for $4.4 Million in gross proceeds. reAlpha Tech Corp.  -10%. Nuzee  -9%. Deutsche Bank  -8%. Blue Hat Interactive Entertainment Technology  -8%. Lichen China Ltd  -7%. Altimmune  -6%. Hub Cyber Security Ltd  -5%. Daqo New Energy Corp  -5% after Q1 earnings release.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095406-alt-cycc-and-db-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2429737454","title":"Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2429737454","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2429737454?lang=en_us&edition=fundamental","pubTime":"2024-04-24 22:30","pubTimestamp":1713969027,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38406512/nasdaq-rises-0-5-tesla-shares-jump-after-q1-results","is_publish_highlight":false,"gpt_icon":0},{"id":"2424876723","title":"Ameren subsidiary selected to develop critical, multiyear grid reliability project in northern Missouri","url":"https://stock-news.laohu8.com/highlight/detail?id=2424876723","media":"PR Newswire","top":-1,"share":"https://ttm.financial/m/news/2424876723?lang=en_us&edition=fundamental","pubTime":"2024-04-04 03:08","pubTimestamp":1712171280,"startTime":"0","endTime":"0","summary":"Project awarded based on sound design plans and lower cost. ST. LOUIS, April 3, 2024 /PRNewswire/ -- A subsidiary of St. Louis-based Ameren Corporation has been selected by the regional transmission operator, the Midcontinent Independent System Operator , to develop a $273 million transmission project across northern Missouri.The project will originate from a new 345-kV substation that ATXI will construct in northwest Missouri and span from DeKalb County to Marion County, opening new pathways for energy transmission to the region. The project is part of a $10 billion portfolio of projects included in Tranche 1 of MISO's Long Range Transmission Plan .ATXI is currently working on additional projects from MISO's Tranche 1 portfolio. The Northern Missouri Grid Transformation Program includes two projects expected to be in-service in 2028. MISO selected ATXI to develop one of these projects in October 2023, noting the sound route design and cost containment plan as key factors.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/HA4Aj7dRhFxy4cRmvF3nOw--~B/aD0xNTM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ff5e71cc9557fbc755f569a1dbdb716c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/HA4Aj7dRhFxy4cRmvF3nOw--~B/aD0xNTM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ff5e71cc9557fbc755f569a1dbdb716c"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ameren-subsidiary-selected-develop-critical-190800684.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ameren-subsidiary-selected-develop-critical-190800684.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2420764255","title":"Navigating the Maze: Avenue Therapeutics Grapples with Regulatory Hurdles for IV Tramadol","url":"https://stock-news.laohu8.com/highlight/detail?id=2420764255","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2420764255?lang=en_us&edition=fundamental","pubTime":"2024-03-20 14:01","pubTimestamp":1710914474,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics (ATXI) has disclosed a new risk, in the Regulation category. Avenue Therapeutics faces substantial regulatory challenges due to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/navigating-the-maze-avenue-therapeutics-grapples-with-regulatory-hurdles-for-iv-tramadol?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/navigating-the-maze-avenue-therapeutics-grapples-with-regulatory-hurdles-for-iv-tramadol?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2420287115","title":"Avenue Therapeutics Q4 EPS $(0.98) Misses $(0.10) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2420287115","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2420287115?lang=en_us&edition=fundamental","pubTime":"2024-03-19 04:15","pubTimestamp":1710792902,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.10) by 880 percent. This is a 20.33 percent increase over losses of $(1.23) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/03/37800428/avenue-therapeutics-q4-eps-0-98-misses-0-10-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2419973232","title":"BRIEF-Avenue Therapeutics Receives Positive Listing Determination from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2419973232","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2419973232?lang=en_us&edition=fundamental","pubTime":"2024-03-15 20:29","pubTimestamp":1710505769,"startTime":"0","endTime":"0","summary":"March 15  - Avenue Therapeutics Inc   :   * AVENUE THERAPEUTICS: NASDAQ PANEL GRANTED REQUEST FOR EXTENSION TO EVIDENCE COMPLIANCE WITH ALL APPLICABLE CRITERIA FOR CONTINUED LISTING ON NASDAQ   * AVENUE THERAPEUTICS INC: NASDAQ GRANTED EXTENSION THROUGH MAY 20, 2024Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2403861426","title":"Sidoti Events, LLC's Virtual January Micro-Cap Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2403861426","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2403861426?lang=en_us&edition=fundamental","pubTime":"2024-01-16 21:40","pubTimestamp":1705412400,"startTime":"0","endTime":"0","summary":"About Sidoti Events, LLC  and Sidoti & Company, LLC In 2023, Sidoti & Company, LLC  formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the 25 years of experience Sidoti had as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 150 equities of which greater than 50 percent participate in the firm's rapidly growing Company Sponsored Research  program. Events is a leading provider of corporate access through the eight investo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/suuCwwLmkfADiAZlJr.sSw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6ee80ee578062ffe571c03dcbe73685c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/suuCwwLmkfADiAZlJr.sSw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6ee80ee578062ffe571c03dcbe73685c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sidoti-events-llcs-virtual-january-134000766.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2401156319","title":"Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2401156319","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2401156319?lang=en_us&edition=fundamental","pubTime":"2024-01-05 22:33","pubTimestamp":1704465209,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics  Friday announced warrant exercise agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 16.5M company shares for proceeds of $5M. In consideration for the immediate exercise of the existing warrants for cash, the company will issue new unregistered Series A warrants to purchase up to 16.5M shares of common stock and new unregistered Series B warrants to purchase up to 16.5M shares of common stock.  The new Series A and Series B warrants would have an exercise price of $0.3006 per underlying share. Source: Press Release    More on Avenue Therapeutics  Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 Avenue Therapeutics stock plummets on pricing of 16.6M units at $0.3006 in public offering Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical earnings data for Avenue Therapeutics Financial information for Avenue Therapeutics","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4052666-avenue-therapeutics-signs-warrant-exercise-transactions-for-50m-in-proceeds","is_publish_highlight":false,"gpt_icon":0},{"id":"2401550783","title":"Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2401550783","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2401550783?lang=en_us&edition=fundamental","pubTime":"2024-01-05 22:15","pubTimestamp":1704464100,"startTime":"0","endTime":"0","summary":"MIAMI, Jan. 05, 2024  -- Avenue Therapeutics, Inc.  , a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the entry into warrant exercise agreements with existing accredited investors for the immediate exercise of certain outstanding warrants to purchase an aggregate of 16.5 million shares of the Company’s common stock. These warrants for immediate exercise include:  November 2023 Series B warrants to purchase an aggregate of 14.6 million shares of common stock issued by Avenue on November 2, 2023, each having an exercise price of $0.3006 per share, and  January 2023 warrants to purchase an aggregate of 1.9 million shares of common stock issued by Avenue on January 31, 2023, each having an exercise price of $1.55 per share, at a reduced exercise price of $0.3006 per share as agreed upon by the Company. The gross proceeds to Avenue from the exercise of the warrants are expected to be a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OI_YNA8UlVdfTIntWDs53g--~B/aD0xMTY3O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/4911f3f6b9732d5c8fc6eb86ddea6f77","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OI_YNA8UlVdfTIntWDs53g--~B/aD0xMTY3O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/4911f3f6b9732d5c8fc6eb86ddea6f77"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avenue-therapeutics-enters-warrant-exercise-141500388.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2401631112","title":"Dow Surges 200 Points; US Services PMI Edges Higher In December","url":"https://stock-news.laohu8.com/highlight/detail?id=2401631112","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2401631112?lang=en_us&edition=fundamental","pubTime":"2024-01-05 02:00","pubTimestamp":1704391227,"startTime":"0","endTime":"0","summary":"U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday.\n\nThe Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10. The S&amp;P 500 also rose, gaining, 0.28% to 4,718.19.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/01/36493797/dow-surges-200-points-us-services-pmi-edges-higher-in-december","is_publish_highlight":false,"gpt_icon":0},{"id":"2401731763","title":"OGEN, RLMD and ATXI among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2401731763","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2401731763?lang=en_us&edition=fundamental","pubTime":"2024-01-05 01:34","pubTimestamp":1704389656,"startTime":"0","endTime":"0","summary":"Gainers: Minim  +142%. Omega Therapeutics  +107%. Avenue Therapeutics  +53%. Mobix Labs  +47%. QuantumScape Corp  +40%. Jeffs Brands Ltd  +29%. Dyne Therapeutics  +28%. Bright Health Group  +26%. Lixiang Education Holding Co Ltd  +26%.  Adicet Bio  +24%.  Losers: E-Home Household Service Holdings  -41%. Relmada Therapeutics  -30%. LifeMD  -30%. Opko Health  -28%. Jin Medical International Ltd  -28%. Mobileye Global  -24%. Hitek Global  -24%. Pinstripes Holdings  -22%. ABVC BioPharma  -20%. Oragenics  -17%.   More on Mid-day movers & Stocks.  Relmada Therapeutics, Inc.  Q3 2023 Earnings Call Transcript Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 Avenue Therapeutics stock plummets on pricing of 16.6M units at $0.3006 in public offering Seeking Alpha’s Quant Rating on Avenue Therapeutics","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4052436-ogen-rlmd-and-atxi-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avenuetx.com","stockEarnings":[{"period":"1week","weight":-0.1632},{"period":"1month","weight":-0.6435},{"period":"3month","weight":-0.6314},{"period":"6month","weight":-0.7625},{"period":"1year","weight":-0.9482},{"period":"ytd","weight":-0.6687}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.014023},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.105438},{"month":3,"riseRate":0.571429,"avgChangeRate":0.067877},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.168509},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.000359},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.069894},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.086956},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.052532},{"month":9,"riseRate":0.142857,"avgChangeRate":0.167724},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.272137},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.039662},{"month":12,"riseRate":0.428571,"avgChangeRate":0.079717}],"exchange":"NASDAQ","name":"Avenue Therapeutics Inc.","nameEN":"Avenue Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avenue Therapeutics Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Avenue Therapeutics Inc.(ATXI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Avenue Therapeutics Inc.,ATXI,Avenue Therapeutics Inc.股票,Avenue Therapeutics Inc.股票老虎,Avenue Therapeutics Inc.股票老虎国际,Avenue Therapeutics Inc.行情,Avenue Therapeutics Inc.股票行情,Avenue Therapeutics Inc.股价,Avenue Therapeutics Inc.股市,Avenue Therapeutics Inc.股票价格,Avenue Therapeutics Inc.股票交易,Avenue Therapeutics Inc.股票购买,Avenue Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avenue Therapeutics Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Avenue Therapeutics Inc.(ATXI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction